High Expression of ACE2 and TMPRSS2 at the Resection Margin Makes Lung Cancer Survivors Susceptible to SARS-CoV-2 With Unfavorable Prognosis
2021 · Frontiers in Oncology · 29 citations
https://doi.org/10.3389/fonc.2021.644575
L
Liangyu Li
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
42
Papers
239
Citations
8
h-index
7
i10-index
Liangyu Li is an academic researcher from North University of China. The author has contributed to research in topics: Advanced Combustion Engine Technologies & Single-cell and spatial transcriptomics & Medical Research and Treatments. The author has an h-index of 8, co-authored 36 publications.
ORCID: 0009-0004-0594-5625Papers by this author
worksIntelligent treatment system based on bioinformatics and neuro-immune-digestive tract diseases
2024 · Alexandria Engineering Journal · 0 citations
https://doi.org/10.1016/j.aej.2024.07.043
Research on Neuroimmune Gastrointestinal Diseases Based on Artificial Intelligence: Molecular Dynamics Analysis of Caffeine and DRD3 Protein
2025 · Current Pharmaceutical Biotechnology · 0 citations
https://doi.org/10.2174/0113892010325902241120111429
Research on Precision Medicine AI Algorithm for Neuro Immune Gastrointestinal Diseases based on Quantum Biochemistry and Computational Cancer Genetics
2025 · Current Pharmaceutical Biotechnology · 0 citations
https://doi.org/10.2174/0113892010348489241210060447
CellGAT: A GAT-Based Method for Constructing a Cell Communication Network Integrating Multiomics Information
2025 · Biomolecules · 0 citations
https://doi.org/10.3390/biom15030342
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat